Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients

Novel therapies for severe dyslipidemia originating from human genetics

(2016) Daniel Gaudet   CURRENT OPINION IN LIPIDOLOGY

Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease

(2016) Frederick E. Dewey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation StudyNovelty and Significance

(2015) Robert D. Shamburek et al.   CIRCULATION RESEARCH

Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia

(2015) C. Liu et al.   Disease Models & Mechanisms

Zebrafish as a model for apolipoprotein biology: comprehensive expression analysis and a role for ApoA-IV in regulating food intake

(2015) J. P. Otis et al.   Disease Models & Mechanisms

Lipoprotein Subfractions Highly Associated With Renal Damage in Familial Lecithin:Cholesterol Acyltransferase Deficiency

(2014) Masayuki Kuroda et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

(2014) Anders Berg Jørgensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting APOC3 in the Familial Chylomicronemia Syndrome

(2014) Daniel Gaudet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Demystifying the management of hypertriglyceridaemia

(2013) Gerald F. Watts et al.   Nature Reviews Cardiology

Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis

(2013) Longhou Fang et al.   Translational Research

Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness

(2012) Bas van den Bogaard et al.   ATHEROSCLEROSIS

Cholesterol Efflux and Atheroprotection

(2012) Robert S. Rosenson et al.   CIRCULATION

A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease

(2012) Anastazia A. Kei et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Triglycerides and Cardiovascular Disease

(2011) Michael Miller et al.   CIRCULATION

Lecithin Cholesterol Acyltransferase: An Anti- or Pro-atherogenic Factor?

(2011) Xavier Rousset et al.   Current Atherosclerosis Reports

Zebrafish: gaining popularity in lipid research

(2010) Maarit Hölttä-Vuori et al.   BIOCHEMICAL JOURNAL

Vascular Lipid Accumulation, Lipoprotein Oxidation, and Macrophage Lipid Uptake in Hypercholesterolemic Zebrafish

(2009) Konstantin Stoletov et al.   CIRCULATION RESEARCH

Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein

(2009) Marcelo J.A. Amar et al.   METABOLISM-CLINICAL AND EXPERIMENTAL